Summary

The global mHealth solutions market is forecast to reach USD 275.44 billion by 2031, up from USD 109.05 billion in 2026, at a CAGR of 20.4% over the forecast period. Government policies and regulatory initiatives increasingly support the adoption of mHealth solutions by establishing frameworks for mobile medical applications, connected medical devices, remote patient monitoring, AI-enabled healthcare software, and digital health infrastructure. In the US, the FDA applies a risk-based regulatory framework to mobile medical applications and device software, while recent 2026 guidance on clinical decision support software and low-risk wellness technologies provides greater clarity for digital health developers. In addition, the FDA launched the TEMPO Digital Health Devices Pilot in 2026 to promote access to certain digital health devices while maintaining patient safety requirements. The Australian Digital Health Agency has developed a national Assessment Framework for mHealth Apps to help consumers and healthcare professionals assess the credibility, safety, usability, and clinical value of mobile health applications. These initiatives provide greater regulatory clarity and confidence around mHealth applications, supporting their development, evaluation, and adoption across the healthcare system.

By offering, the mHealth services segment is growing at a significant rate during the forecast period.
mHealth services are experiencing significant growth as healthcare systems increasingly adopt technology-enabled models for continuous, remote, and home-based care. This expansion is driven by the growing prevalence of chronic diseases, the need for continuous patient monitoring, rising demand for home healthcare, and the increasing use of connected medical devices that transmit health information to healthcare providers. For example, Philips' Care Orchestrator enables healthcare providers to remotely monitor and manage patients with sleep apnea and respiratory conditions, receive adherence and clinical reports, and prioritize patients who require intervention.

By end user, the healthcare providers segment held a significant share of the MHealth solutions market in 2025.
By end user, the mHealth solutions market is segmented into patients/consumers, healthcare providers, healthcare payers, and other end users. This segmentation is driven by the growing adoption of digital technologies to improve patient monitoring, clinical decision-making, care coordination, and healthcare delivery. Hospitals, clinics, and other healthcare providers are increasingly integrating mHealth applications, connected medical devices, and remote monitoring services into clinical workflows to enable continuous access to patient data and support timely interventions. The rising prevalence of chronic diseases and the shift toward value-based and home-based care are further encouraging healthcare providers to adopt mHealth solutions. For example, remote patient monitoring enables providers to receive patient-generated health data from connected devices such as blood pressure monitors, glucose monitors, and pulse oximeters, and to use this information to manage patients remotely.

Asia Pacific is expected to register the fastest growth during the forecast period.
Asia Pacific is expected to be the fastest-growing region in the mHealth solutions market, supported by rapid digitalization of healthcare, expanding mobile connectivity, rising chronic disease burden, and increasing demand for remote and home-based care. Government initiatives across the region are further strengthening the digital-health ecosystem. In China, the government continues to expand the “Internet + Healthcare” model, with internet hospitals and online medical services increasing access to remote consultations and digitally enabled care. By 2025, China's internet-healthcare regulatory platform had achieved provincial-level coverage, and the number of internet hospitals had increased significantly. The government is also promoting mobile medical applications, remote consultations, and connected healthcare services, including through the “Broadband Network + Healthy Rural Areas” pilot, which included 117 projects, of which 37 focused on remote medical services. These initiatives are strengthening the region's digital-health infrastructure and creating opportunities for mHealth applications, telehealth, remote patient monitoring, and connected medical devices.

The break-down of primary participants is as mentioned below:
・By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
・By Designation - Directors: 30%, Manager: 34%, and Others: 36%
・By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%
Key Players
The prominent players operating in the mHealth solutions market include Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Abbott (US), ResMed (US), Dexcom, Inc. (US), GE HealthCare (US), athenahealth (US), Optum (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, and mergers & acquisitions to strengthen their presence in the mHealth solutions market.
Research Coverage
The report analyzes the mHealth solutions market and estimates the market size and future growth potential of various segments based on offering, use case, end user, and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It evaluates opportunities and challenges for market stakeholders. The report also studies micro-markets with respect to their growth trends, prospects, and contributions to the total mHealth solutions market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will help established firms as well as new entrants and smaller firms gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or more of the following strategies to strengthen their positions in the market.
This report provides insights into:
・Analysis of key drivers (increasing penetration of smartphones, tablets, and other mobile platforms, increasing utilization of connected devices and mHealth apps to manage chronic diseases, cost containment in healthcare delivery, rising focus on patient-centric healthcare delivery, increasing demand for home healthcare services), restraints (lack of standards & regulations and sufficient reimbursement), opportunities (Growing adoption across emerging markets, growing adoption of mHealth solutions in mobile platforms), challenges (patent protection for mHealth devices and app, lack of data security and concerns regarding data theft and healthcare fraud) are factors contributing the growth of the mHealth solutions market.
・Product Development/Innovation: Detailed insights into upcoming trends, research & development activities, and software launches in the mHealth solutions market
・Market Development: Comprehensive information on lucrative emerging markets, type of offering, use case, end user, and region
・Market Diversification: Exhaustive information about software portfolios, growing geographies, recent developments, and investments in mHealth solutions market
・Competitive Assessment: In-depth assessment of market share, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global mHealth solutions market, such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), Abbott (US), ResMed (US), Dexcom, Inc. (US), GE HealthCare (US), athenahealth (US), Optum (US), Teladoc Health (US), AliveCor, Inc. (US), among others

ページTOPに戻る

Table of Contents

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.3 MARKET SCOPE 33
1.3.1 MARKET SEGMENTATION 33
1.3.2 INCLUSIONS & EXCLUSIONS 34
1.3.3 YEARS CONSIDERED 35
1.3.4 CURRENCY CONSIDERED 35
1.4 LIMITATIONS 36
1.5 STAKEHOLDERS 36
1.6 SUMMARY OF CHANGES 37
2 EXECUTIVE SUMMARY 38
2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 38
2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 39
2.3 DISRUPTIVE TRENDS SHAPING MARKET 40
2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS 41
2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 42
3 PREMIUM INSIGHTS 43
3.1 MHEALTH SOLUTIONS MARKET OVERVIEW 43
3.2 MHEALTH SOLUTIONS MARKET, BY OFFERING & REGION 44
3.3 MHEALTH SOLUTIONS MARKET: GEOGRAPHIC SNAPSHOT 45
4 MARKET OVERVIEW 46
4.1 INTRODUCTION 46
4.2 MARKET DYNAMICS 46
4.2.1 DRIVERS 47
4.2.1.1 Increasing penetration of smartphones, tablets, and other mobile platforms 47
4.2.1.2 Rising focus on patient-centric healthcare delivery 47
4.2.1.3 Rapid adoption of wearables expands connected mHealth ecosystems 48
4.2.1.4 Chronic disease burden drives demand for remote monitoring and connected devices 48
4.2.2 RESTRAINTS 49
4.2.2.1 Complexity of regulatory landscape 49
4.2.2.2 Fragmentation of mHealth ecosystem 49
4.2.2.3 Interoperability constraints 50
4.2.3 OPPORTUNITIES 50
4.2.3.1 AI and predictive analytics expand mHealth capabilities 50
4.2.3.2 Growing adoption across emerging markets 51
4.2.3.3 Strategic partnerships and collaborations among healthcare companies and mHealth providers 52
4.2.3.4 Telehealth growth expands mobile care delivery 52
4.2.4 CHALLENGES 53
4.2.4.1 Reimbursement barriers restrict wider mHealth adoption 53
4.2.4.2 Concerns associated with data security 53
4.2.4.3 Rapid Technology Evolution Increases mHealth Development Complexity 54
4.3 UNMET NEEDS AND WHITE SPACES 55
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 56
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 56
5 INDUSTRY TRENDS 57
5.1 PORTER’S FIVE FORCES ANALYSIS 57
5.1.1 THREAT OF NEW ENTRANTS 58
5.1.2 THREAT OF SUBSTITUTES 58
5.1.3 BARGAINING POWER OF SUPPLIERS 59
5.1.4 BARGAINING POWER OF BUYERS 59
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 59
5.2 MACROECONOMIC INDICATORS 59
5.2.1 INTRODUCTION 59
5.2.2 GDP TRENDS AND FORECAST 59
5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 60
5.3 VALUE CHAIN ANALYSIS 60
5.4 ECOSYSTEM ANALYSIS 61
5.5 PRICING ANALYSIS 62
5.5.1 INDICATIVE PRICE FOR MHEALTH SOLUTIONS, BY END USER (2025) 63
5.5.2 INDICATIVE PRICE FOR MHEALTH SOLUTIONS MARKET, BY REGION (2025) 63
5.6 KEY CONFERENCES AND EVENTS, 2026–2027 64
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 65
5.8 INVESTMENT AND FUNDING SCENARIO 65
5.9 CASE STUDY ANALYSIS 66
5.9.1 CASE 1: CASE STUDY 1: CLÍNICAS DEL AZÚCAR (CDA) 66
5.9.2 CASE STUDY 2: NOVA HOSPITAL & ENOVACOM 67
5.9.3 CASE STUDY 3: APPLE & NHS TEAMS 67
5.10 IMPACT OF 2025 US TARIFF – OVERVIEW 68
5.10.1 INTRODUCTION 68
5.10.2 KEY TARIFF RATES 69
5.10.3 PRICE IMPACT ANALYSIS 70
5.10.4 IMPACT ON COUNTRY/REGION 71
5.10.4.1 US 71
5.10.4.2 Europe 71
5.10.4.3 Asia Pacific 71
5.10.5 IMPACT ON END USERS 72
5.10.5.1 Healthcare providers 72
5.10.5.2 Healthcare payers 72
5.10.5.3 Patients and consumers 73
5.10.5.4 Other end users (Academic institutes, research centers, government bodies, etc.) 73
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 74
6.1 KEY EMERGING TECHNOLOGIES 74
6.1.1 AI AND MACHINE LEARNING 74
6.1.2 5G/6G CONNECTIVITY 74
6.1.3 DIGITAL BIOMARKERS 74
6.1.4 COMPLEMENTARY TECHNOLOGIES 74
6.1.5 CONNECTED MEDICAL DEVICES 74
6.1.6 CLOUD COMPUTING 75
6.1.7 TELEMEDICINE PLATFORMS 75
6.1.8 ADJACENT TECHNOLOGIES 75
6.1.8.1 Precision medicine 75
6.1.8.2 Clinical decision support systems 75
6.1.8.3 Healthcare data analytics 75
6.2 PATENT ANALYSIS 76
6.2.1 PATENT PUBLICATION TRENDS FOR THE MHEALTH SOLUTIONS 76
6.2.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 76
6.3 FUTURE APPLICATIONS 78
6.3.1 AI-POWERED PREDICTIVE HEALTH MONITORING 79
6.3.2 PERSONALIZED DIGITAL HEALTH COACHING 79
6.3.3 CONTINUOUS REMOTE PATIENT MONITORING 79
6.3.4 AI-ENABLED EARLY DISEASE DETECTION 79
6.3.5 MOBILE MEDICATION ADHERENCE AND MANAGEMENT 79
6.4 IMPACT OF AI/GEN AI ON MHEALTH SOLUTIONS MARKET 80
6.4.1 INTRODUCTION 80
6.4.2 MARKET POTENTIAL OF AI/GEN AI IN MHEALTH SOLUTIONS MARKET 81
6.4.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 82
6.4.3.1 Cottage health expands AI-assisted virtual care and patient safety platform enterprise-wide 82
6.4.3.2 Apollo Hospitals deploys AI-enabled connected care across healthcare continuum 83
6.4.4 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 84
6.4.4.1 AI-powered symptom assessment & triage 84
6.4.4.2 Predictive health analytics 84
6.4.4.3 Conversational health assistants 85
6.4.4.4 Medication & treatment support 85
6.4.5 USER READINESS AND IMPACT ASSESSMENT 85
6.4.5.1 User readiness 85
6.4.5.1.1 Healthcare providers 85
6.4.5.1.2 Healthcare payers 85
6.4.5.1.3 Patients/Consumers 86
6.4.5.2 Impact assessment 86
6.4.5.2.1 User A: Healthcare providers 86
6.4.5.2.1.1 Implementation 86
6.4.5.2.1.2 Impact 86
6.4.5.2.2 User B: Healthcare payers 86
6.4.5.2.2.1 Implementation 86
6.4.5.2.2.2 Impact 87
6.4.5.2.3 User B: Patients/Consumers 87
6.4.5.2.3.1 Implementation 87
6.4.5.2.3.2 Impact 87
6.4.6 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS 87
6.4.7 REGULATORY ANALYSIS 92
7 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 96
7.1 INTRODUCTION 96
7.2 DECISION-MAKING PROCESS 96
7.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 96
7.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
7.3.2 BUYING CRITERIA 97
7.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 98
7.5 UNMET NEEDS FROM VARIOUS END USERS 99
7.5.1 UNMET NEEDS 99
7.5.2 END USER EXPECTATIONS 100
7.6 MARKET PROFITABILITY 101
8 MHEALTH SOLUTIONS MARKET, BY OFFERING 102
8.1 INTRODUCTION 103
8.2 MHEALTH APPS 103
8.2.1 GROWING ADOPTION FOR PERSONALIZED AND CONNECTED HEALTHCARE TO DRIVE SEGMENT 103
8.2.2 CHRONIC CARE MANAGEMENT APPS 105
8.2.2.1 Increasing need for continuous, personalized chronic care management to boost demand 105
8.2.3 MENTAL & BEHAVIORAL HEALTH APPS 106
8.2.3.1 Growing demand for accessible and convenient mental healthcare to drive segment 106
8.2.4 GENERAL HEALTH & FITNESS APPS 107
8.2.4.1 Focus on personalized health, fitness, and wellness management to propel segment 107
8.2.5 MEDICATION MANAGEMENT & ADHERENCE APPS 108
8.2.5.1 Segment driven by need for improved medication adherence and treatment management 108
8.2.6 WOMEN’S HEALTH APPS 109
8.2.6.1 Rapid adoption of mobile technologies for personalized women’s health management 109
8.2.7 DIAGNOSTIC & SYMPTOM CHECKER APPS 110
8.2.7.1 Increasing need for convenient digital health assessment and diagnostic support to drive segment 110
8.2.8 PATIENT HEALTH RECORDS APPS/PATIENT PORTAL APPS 111
8.2.8.1 Growing need for accessible and connected patient health information to boost market 111
8.2.9 CLINICAL DECISION SUPPORT APPS 112
8.2.9.1 Rapid adoption of medical applications for clinical monitoring and decision support to drive segment 112
8.2.10 OTHER HEALTHCARE APPS 112
8.2.10.1 High demand for digital healthcare information and patient engagement to grow market 112
8.3 CONNECTED MEDICAL DEVICES 113
8.3.1 ADVANCING CONNECTED TECHNOLOGIES FOR CONTINUOUS AND PERSONALIZED HEALTH MONITORING TO DRIVE MARKET 113
8.3.2 VITAL SIGNS MONITORING DEVICES 115
8.3.2.1 Expanding role of connected monitoring in continuous patient assessment to boost segment 115
8.3.3 SLEEP MONITORING DEVICES 115
8.3.3.1 Advancing connected technologies for sleep health management 115
8.3.4 MULTIPARAMETER & REMOTE PATIENT MONITORING DEVICES 116
8.3.4.1 Increasing integration of multiparameter monitoring across care settings to boost market 116
8.3.5 FETAL & MATERNAL MONITORING DEVICES 117
8.3.5.1 Enhanced maternal and fetal care through wireless monitoring to drive segment 117
8.3.6 NEUROLOGICAL MONITORING DEVICES 118
8.3.6.1 Segment driven by advances in connected technologies for neurological monitoring 118
8.3.7 SMART INHALERS & DRUG DELIVERY DEVICES 119
8.3.7.1 Improved medication management through connected drug delivery to boost market 119
8.3.8 OTHER CONNECTED MEDICAL DEVICES 120
8.3.8.1 Broadening applications of connected devices in specialized healthcare 120
8.4 MHEALTH SERVICES 121
8.4.1 EXPANDING ACCESS TO CONNECTED AND PATIENT-CENTRIC HEALTHCARE SERVICES TO BOOST MARKET 121
8.4.2 REMOTE PATIENT MONITORING SERVICES 123
8.4.2.1 Extending clinical oversight beyond traditional care settings – key driver 123
8.4.3 TELEHEALTH SERVICES 124
8.4.3.1 Broad access to virtual and on-demand healthcare to boost demand 124
8.4.4 DIGITAL DISEASE MANAGEMENT SERVICES 125
8.4.4.1 Shifting chronic disease management toward continuous digital care 125
8.4.5 OTHERS 126
8.4.5.1 Connected care strengthened through implementation, support, and digital rehabilitation 126
9 MHEALTH SOLUTIONS MARKET, BY USE CASE 127
9.1 INTRODUCTION 128
9.2 PREVENTIVE CARE & WELLNESS 128
9.2.1 AI AND WEARABLES DRIVE PREVENTIVE MHEALTH ADOPTION 128
9.3 SCREENING & DIAGNOSIS 129
9.3.1 MOBILE AND AI-ENABLED TOOLS EXPANDING ACCESS TO EARLY SCREENING & DIAGNOSIS 129
9.4 TREATMENT & DISEASE MANAGEMENT 130
9.4.1 CONNECTED DEVICES AND DIGITAL THERAPEUTICS STRENGTHENING MHEALTH-BASED DISEASE MANAGEMENT 130
9.5 PATIENT MONITORING 131
9.5.1 WEARABLES AND REMOTE MONITORING ENABLE CONTINUOUS PATIENT OVERSIGHT 131
9.6 MEDICATION MANAGEMENT & ADHERENCE 132
9.6.1 MOBILE PLATFORMS AND DIGITAL TOOLS IMPROVING MEDICATION ADHERENCE 132
9.7 CONSULTING & CARE COORDINATION 133
9.7.1 DIGITAL CONNECTIVITY ENABLES ENHANCED COORDINATED CARE DELIVERY 133
9.8 REHABILITATION & RECOVERY 134
9.8.1 DIGITAL REHABILITATION EXTENDS RECOVERY BEYOND TRADITIONAL THERAPY SETTINGS 134
9.9 OTHERS 135
9.9.1 MOBILE HEALTH EXPANDS POPULATION-LEVEL HEALTH EDUCATION AND AWARENESS 135
10 MHEALTH SOLUTIONS MARKET, BY END USER 137
10.1 INTRODUCTION 138
10.2 PATIENTS/CONSUMERS 138
10.2.1 PERSONALIZED AND CONVENIENT HEALTHCARE TO LEAD TO MARKET GROWTH 138
10.3 HEALTHCARE PROVIDERS 139
10.3.1 HEALTHCARE PROVIDERS INTEGRATING MHEALTH INTO CONNECTED CARE DELIVERY 139
10.4 HEALTHCARE PAYERS 140
10.4.1 LEVERAGING MHEALTH TO IMPROVE OUTCOMES AND MANAGE HEALTHCARE COSTS 140
10.5 OTHER END USERS 141
10.5.1 SCALED MHEALTH FOR POPULATION-LEVEL HEALTHCARE TO DRIVE SEGMENT 141
11 MHEALTH SOLUTIONS MARKET, BY REGION 143
11.1 INTRODUCTION 144
11.2 NORTH AMERICA 144
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 146
11.2.2 US 150
11.2.2.1 Market driven by RPM and telehealth expansion 150
11.2.3 CANADA 154
11.2.3.1 Market driven by digital adoption and interoperability 154
11.3 EUROPE 158
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 158
11.3.2 GERMANY 162
11.3.2.1 DiGA reimbursement and digital health integration to drive market 162
11.3.3 UK 166
11.3.3.1 Market driven by NHS digitalization and AI adoption 166
11.3.4 FRANCE 170
11.3.4.1 Market driven by telemonitoring and digital health infrastructure 170
11.3.5 ITALY 174
11.3.5.1 Market driven by PNRR, telemedicine, and EHR expansion 174
11.3.6 SPAIN 178
11.3.6.1 Rising funding for digital health plans to boost market 178
11.3.7 REST OF EUROPE 182
11.4 ASIA PACIFIC 186
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 186
11.4.2 CHINA 191
11.4.2.1 Market driven by internet healthcare and AI-enabled care 191
11.4.3 JAPAN 195
11.4.3.1 Rising geriatric population and subsequent rise in preventive care to drive market 195
11.4.4 INDIA 199
11.4.4.1 Government initiatives and digital health to drive market growth 199
11.4.5 AUSTRALIA 203
11.4.5.1 Growing remote monitoring and connected health records expansion to drive market 203
11.4.6 SOUTH KOREA 207
11.4.6.1 Strategic partnerships and AI innovations accelerating mHealth adoption 207
11.4.7 REST OF ASIA PACIFIC 211
11.5 LATIN AMERICA 215
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 215
11.5.2 BRAZIL 219
11.5.2.1 Market driven by SUS digitalization and connected care 219
11.5.3 MEXICO 223
11.5.3.1 Market driven by AI-enabled chronic care 223
11.5.4 REST OF LATIN AMERICA 227
11.6 MIDDLE EAST & AFRICA 231
11.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 231
11.7.1 GCC 235
11.7.1.1 Market driven by virtual hospitals and AI-enabled care 235
11.7.2 SAUDI ARABIA 239
11.7.2.1 Expanding connected healthcare ecosystem to boost market 239
11.7.3 UAE 243
11.7.3.1 Connected records and smart health apps to boost market 243
11.7.4 REST OF GCC 247
11.7.4.1 Strengthening of connected healthcare ecosystems through digital health transformation to propel market 247
11.7.5 SOUTH AFRICA 251
11.7.5.1 Market driven by mobile health and digital public healthcare 251
11.7.6 REST OF MIDDLE EAST & AFRICA 255
12 COMPETITIVE LANDSCAPE 259
12.1 INTRODUCTION 259
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 259
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MHEALTH SOLUTIONS MARKET 259
12.3 REVENUE ANALYSIS, 2021–2025 261
12.4 MARKET SHARE ANALYSIS, 2025 262
12.4.1 RANKING OF KEY MARKET PLAYERS 264
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 265
12.5.1 STARS 265
12.5.2 EMERGING LEADERS 265
12.5.3 PERVASIVE PLAYERS 265
12.5.4 PARTICIPANTS 265
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 267
12.5.5.1 Company footprint 267
12.5.5.2 Regional footprint 268
12.5.5.3 Offering footprint 269
12.5.5.4 Use case footprint 270
12.5.5.5 End user footprint 271
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 272
12.6.1 PROGRESSIVE COMPANIES 272
12.6.2 RESPONSIVE COMPANIES 272
12.6.3 DYNAMIC COMPANIES 272
12.6.4 STARTING BLOCKS 272
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 274
12.6.5.1 Detailed list of key startups/SMEs 274
12.6.5.2 Company footprint (startups/SMEs) 274
12.7 COMPANY VALUATION AND FINANCIAL METRICS 275
12.7.1 FINANCIAL METRICS 275
12.7.2 COMPANY VALUATION 275
12.8 BRAND/PRODUCT COMPARISON 276
12.9 COMPETITIVE SCENARIO 277
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 277
12.9.2 DEALS 278
12.9.3 OTHER DEVELOPMENTS 279
13 COMPANY PROFILES 280
13.1 KEY PLAYERS 280
13.1.1 KONINKLIJKE PHILIPS N.V. 280
13.1.1.1 Business overview 280
13.1.1.2 Products & services offered 282
13.1.1.3 Recent developments 283
13.1.1.3.1 Product/Service launches & approvals 283
13.1.1.3.2 Deals 284
13.1.1.3.3 Expansions 286
13.1.1.3.4 Other developments 286
13.1.1.4 MnM view 287
13.1.1.4.1 Right to win 287
13.1.1.4.2 Strategic choices 287
13.1.1.4.3 Weaknesses & competitive threats 287
13.1.2 MEDTRONIC 288
13.1.2.1 Business overview 288
13.1.2.2 Products & services offered 290
13.1.2.3 Recent developments 291
13.1.2.3.1 Product/Service launches & approvals 291
13.1.2.3.2 Deals 292
13.1.2.4 MnM view 293
13.1.2.4.1 Right to win 293
13.1.2.4.2 Strategic choices 294
13.1.2.4.3 Weaknesses & competitive threats 294
13.1.3 ABBOTT 295
13.1.3.1 Business overview 295
13.1.3.2 Products & services offered 296
13.1.3.3 Recent developments 298
13.1.3.3.1 Product/Service launches & approvals 298
13.1.3.3.2 Deals 298
13.1.3.4 MnM view 299
13.1.3.4.1 Right to win 299
13.1.3.4.2 Strategic choices 299
13.1.3.4.3 Weaknesses & competitive threats 299
13.1.4 RESMED 300
13.1.4.1 Business overview 300
13.1.4.2 Products & services offered 302
13.1.4.3 Recent developments 303
13.1.4.3.1 Product/Service launches & approvals 303
13.1.4.3.2 Deals 304
13.1.4.4 MnM view 305
13.1.4.4.1 Right to win 305
13.1.4.4.2 Strategic choices 305
13.1.4.4.3 Weaknesses & competitive threats 305
13.1.5 DEXCOM, INC. 306
13.1.5.1 Business overview 306
13.1.5.2 Products & services offered 308
13.1.5.3 Recent developments 309
13.1.5.3.1 Product/Service launches & approvals 309
13.1.5.3.2 Deals 310
13.1.5.4 MnM view 311
13.1.5.4.1 Right to win 311
13.1.5.4.2 Strategic choices 311
13.1.5.4.3 Weaknesses & competitive threats 311
13.1.6 GE HEALTHCARE 312
13.1.6.1 Business overview 312
13.1.6.2 Products & services offered 313
13.1.6.3 Recent developments 314
13.1.6.3.1 Product/Service launches & approvals 314
13.1.6.3.2 Deals 315
13.1.6.3.3 Other developments 316
13.1.7 OMRON HEALTHCARE, INC. 317
13.1.7.1 Business overview 317
13.1.7.2 Products & services offered 318
13.1.7.3 Recent developments 319
13.1.7.3.1 Product/Service launches & approvals 319
13.1.7.4 Recent developments 320
13.1.7.4.1 Deals 320
13.1.8 ORACLE 321
13.1.8.1 Business overview 321
13.1.8.2 Products & services offered 322
13.1.8.3 Recent developments 323
13.1.8.3.1 Product/Service launches & approvals 323
13.1.8.3.2 Deals 323
13.1.8.3.3 Expansions 324
13.1.9 BOSTON SCIENTIFIC CORPORATION 325
13.1.9.1 Business overview 325
13.1.9.2 Products & services offered 326
13.1.9.3 Recent developments 327
13.1.9.3.1 Product/Service launches & approvals 327
13.1.9.4 Recent developments 327
13.1.9.4.1 Deals 327
13.1.10 SIEMENS HEALTHCARE PRIVATE LIMITED 328
13.1.10.1 Business overview 328
13.1.10.2 Products & services offered 329
13.1.10.3 Recent developments 330
13.1.10.3.1 Product/Service launches & approvals 330
13.1.10.3.2 Expansions 330
13.1.11 OPTUM 331
13.1.11.1 Business overview 331
13.1.11.2 Products & services offered 332
13.1.11.3 Recent developments 333
13.1.11.3.1 Deals 333
13.1.12 ATHENAHEALTH 334
13.1.12.1 Business overview 334
13.1.12.2 Products & services offered 334
13.1.12.3 Recent developments 335
13.1.12.3.1 Product/Service launches & approvals 335
13.1.12.3.2 Deals, January 2023-July 2026 335
13.1.13 EMPATICA INC. 336
13.1.13.1 Business overview 336
13.1.13.2 Products & services offered 336
13.1.13.3 Recent developments 337
13.1.13.3.1 Product/Service launches & approvals 337
13.1.13.3.2 Deals 338
13.1.13.3.3 Expansions 339
13.1.14 TELADOC HEALTH, INC. 340
13.1.14.1 Business overview 340
13.1.14.2 Products & services offered 341
13.1.14.3 Recent developments 342
13.1.14.3.1 Product/Service launches & approvals 342
13.1.14.3.2 Deals 343
13.1.15 WELLDOC, INC. 344
13.1.15.1 Business overview 344
13.1.15.2 Products & services offered 344
13.1.15.3 Recent developments 345
13.1.15.3.1 Product/Service launches & approvals 345
13.1.15.3.2 Deals 345
13.1.16 ALIVECOR, INC. 347
13.1.16.1 Business overview 347
13.1.16.2 Products & services offered 347
13.1.16.3 Recent developments 348
13.1.16.3.1 Product/Service launches & approvals 348
13.1.16.3.2 Deals 349
13.1.17 BIOFOURMIS 350
13.1.17.1 Business overview 350
13.1.17.2 Products & services offered 350
13.1.17.3 Recent developments 351
13.1.17.3.1 Deals 351
13.1.18 TUNSTALL GROUP 352
13.1.18.1 Business overview 352
13.1.18.2 Products & services offered 352
13.1.19 GARMIN LTD. 353
13.1.19.1 Business overview 353
13.1.19.2 Products & services offered 354
13.1.19.3 Recent developments 355
13.1.19.3.1 Product/Service launches & approvals 355
13.1.19.3.2 Deals 356
13.1.20 AIRSTRIP TECHNOLOGIES, INC 357
13.1.20.1 Business overview 357
13.1.20.2 Products & services offered 357
13.1.20.3 Recent developments 358
13.1.20.3.1 Product/Service launches & approvals 358
13.1.20.3.2 Deals 359
13.2 OTHER PLAYERS 360
13.2.1 NATURAL CYCLES NORDIC AB 360
13.2.2 SIDEKICK HEALTH 361
13.2.3 BUOY HEALTH, INC. 362
13.2.4 VIASUALDX 363
13.2.5 FIMO HEALTH 364
14 RESEARCH METHODOLOGY 365
14.1 RESEARCH DATA 365
14.1.1 SECONDARY DATA 366
14.1.1.1 Key data from secondary sources 366
14.1.2 PRIMARY DATA 367
14.1.2.1 Key data from primary sources 368
14.1.2.2 Breakdown of primary sources 369
14.2 MARKET SIZE ESTIMATION 370
14.3 MARKET SIZE ESTIMATION 371
14.4 MARKET BREAKDOWN DATA TRIANGULATION 376
14.5 MARKET SHARE ESTIMATION 377
14.6 STUDY ASSUMPTIONS 377
14.7 RESEARCH LIMITATIONS 377
14.7.1 METHODOLOGY-RELATED LIMITATIONS 377
14.8 RISK ASSESSMENT 378
15 APPENDIX 379
15.1 DISCUSSION GUIDE 379
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 384
15.3 CUSTOMIZATION OPTIONS 386
15.4 RELATED REPORTS 386
15.5 AUTHOR DETAILS 387